Danh mục

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: A retrospective cross-sectional analysis

Số trang: 11      Loại file: pdf      Dung lượng: 912.93 KB      Lượt xem: 6      Lượt tải: 0    
Hoai.2512

Phí tải xuống: 3,000 VND Tải xuống file đầy đủ (11 trang) 0
Xem trước 2 trang đầu tiên của tài liệu này:

Thông tin tài liệu:

Based on the mechanism of action, combining somatostatin analogues (SSAs) with mTOR inhibitors or antiangiogenic agents may provide synergistic effects for the treatment of patients with neuroendocrine tumours (NETs). Herein, we investigate the use of these treatment combinations in clinical practice.
Nội dung trích xuất từ tài liệu:
Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: A retrospective cross-sectional analysis

Tài liệu được xem nhiều: